Introduction
Flow cytometry is a powerful tool for identifying components of the immune system. In human medicine, immunophenotyping of individual patient's cells can identify changes in subpopulations that characterize different clinical conditions, such as AIDS. As in human medicine, veterinary medicine is also applying flow cytometry to clinical cases. As more reagents become available, the technique is being applied to a greater variety of conditions for diagnosis and prognosis (reviewed this issue, Chabanne).
Flow cytometry gating in human medicine is critical for establishing the correct cell population for analysis. Backgating techniques, using antibodies to CD45 and CD14, help to diminish the subjective qualities of selecting a population of cells for analysis. It is done by selecting a population of cells that bind a discriminating antibody or antibodies and then examining the distribution of those cells by forward and side scatter to determine gate purity. Gate purity is the percentage of the cells you have gated on that are within the target population for analysis. The final gate on forward/side scatter plot can then be adjusted to increase the percentage of targeted cells in the gate, and reduce the number of non-targeted, contaminating cells. Antibodies to both CD45 and CD14 are used in human medicine to gate on the correct population for analysis.
Applications of flow cytometry in veterinary medicine have been limited by the lack of reagents. More antibodies, however, are becoming commercially available. It is essential that any antibodies used be well characterized as to the molecular weight of the antigen it binds, the antigen's distribution in lymphoid tissue, as well as the distribution of the antigen in a species. This assures the user that the antibody recognizes the antigen homologue in the species. Well characterized antibodies to canine and feline lymphocytes, CD4, and CD8 can be purchased from commercial sources (Tables 1 and 2 ). In addition, antibodies to canine and feline CD45 are also now available (Tables 1 and 2 ). Monoclonal antibodies to CD14 are not yet commercially available for domestic species. To overcome these deficiencies, a standardized gating technique is described that uses antibodies to T-lymphocytes and establishes standards for gated T-lymphocytes of 75% in cats and 80% in dogs [1]. Abbreviations: ACD = acid citrate dextrose; AIDS = acquired immunodeficiency syndrome; ufH 2 O = distilled, deionized, ultrafiltered water are not available widely across species. In veterinary medicine, markers to identify lymphocytes are usually limited to T-lymphocyte, CD4, CD8, and Blymphocyte surface antigens. A standardized gating technique using a T-lymphocyte antibody is described and is applicable across species where limited phenotype markers are available. 
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